Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322834306> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2322834306 endingPage "75" @default.
- W2322834306 startingPage "67" @default.
- W2322834306 abstract "Almost all Japanese epidemiological studies showed that all-cause mortality was lower in subjects with high serum total or LDL-cholesterol levels. Studies showing the disadvantage of high cholesterol levels included or were likely to include more participants with FH than in the general Japanese population. This also explains why epidemiological studies with elderly people are not able to detect any disadvantage of high cholesterol levels; groups of elderly subjects contain a smaller proportion of vulnerable FH patients who die earlier than those without FH. Meta-analyses of the effects of statins were used to indicate the favorable effects of these drugs, which might be considered as proof that cholesterol has unfavorable effects. However, the absolute effect size of statins on all-cause mortality is rather small, if any. Moreover, studies included in meta-analyses of statins were performed before the new clinical research regulation came into effect in 2005-2006 in the EU, which required clinical trial results to be published even if the data were not favorable for the tested drugs (BJOG 2007; 114: 917, http://www.bjog.org/view/0/index.html). Considering the fact that placebo-controlled clinical trials performed after the new regulation were mostly negative (J Lipid Nutr 2010; 19: 65, http://www.jstage.jst.go.jp/article/jln/19/1/65/_pdf/-char/ja/), the results published before the regulation were questionable and should not be used as the basis for recommendations for treatment with cholesterol-lowering medications. Because the relative risks of high cholesterol for CHD vary from <1 to >5, administering cholesterol-lowering medications to all Japanese individuals equally is not rational; at least women and elderly men need to be carefully re-examined because no or little positive associations between plasma cholesterol and CHD mortality rates have been reported in these groups." @default.
- W2322834306 created "2016-06-24" @default.
- W2322834306 creator A5001451102 @default.
- W2322834306 creator A5008008608 @default.
- W2322834306 creator A5014965523 @default.
- W2322834306 creator A5061345986 @default.
- W2322834306 creator A5070116875 @default.
- W2322834306 creator A5078109225 @default.
- W2322834306 date "2012-01-01" @default.
- W2322834306 modified "2023-10-16" @default.
- W2322834306 title "Rethinking Cholesterol Issues" @default.
- W2322834306 doi "https://doi.org/10.4010/jln.21.67" @default.
- W2322834306 hasPublicationYear "2012" @default.
- W2322834306 type Work @default.
- W2322834306 sameAs 2322834306 @default.
- W2322834306 citedByCount "3" @default.
- W2322834306 countsByYear W23228343062013 @default.
- W2322834306 countsByYear W23228343062018 @default.
- W2322834306 crossrefType "journal-article" @default.
- W2322834306 hasAuthorship W2322834306A5001451102 @default.
- W2322834306 hasAuthorship W2322834306A5008008608 @default.
- W2322834306 hasAuthorship W2322834306A5014965523 @default.
- W2322834306 hasAuthorship W2322834306A5061345986 @default.
- W2322834306 hasAuthorship W2322834306A5070116875 @default.
- W2322834306 hasAuthorship W2322834306A5078109225 @default.
- W2322834306 hasBestOaLocation W23228343061 @default.
- W2322834306 hasConcept C107130276 @default.
- W2322834306 hasConcept C126322002 @default.
- W2322834306 hasConcept C142724271 @default.
- W2322834306 hasConcept C17744445 @default.
- W2322834306 hasConcept C199539241 @default.
- W2322834306 hasConcept C204787440 @default.
- W2322834306 hasConcept C27081682 @default.
- W2322834306 hasConcept C2777673361 @default.
- W2322834306 hasConcept C2778163477 @default.
- W2322834306 hasConcept C2908647359 @default.
- W2322834306 hasConcept C535046627 @default.
- W2322834306 hasConcept C71924100 @default.
- W2322834306 hasConcept C99454951 @default.
- W2322834306 hasConceptScore W2322834306C107130276 @default.
- W2322834306 hasConceptScore W2322834306C126322002 @default.
- W2322834306 hasConceptScore W2322834306C142724271 @default.
- W2322834306 hasConceptScore W2322834306C17744445 @default.
- W2322834306 hasConceptScore W2322834306C199539241 @default.
- W2322834306 hasConceptScore W2322834306C204787440 @default.
- W2322834306 hasConceptScore W2322834306C27081682 @default.
- W2322834306 hasConceptScore W2322834306C2777673361 @default.
- W2322834306 hasConceptScore W2322834306C2778163477 @default.
- W2322834306 hasConceptScore W2322834306C2908647359 @default.
- W2322834306 hasConceptScore W2322834306C535046627 @default.
- W2322834306 hasConceptScore W2322834306C71924100 @default.
- W2322834306 hasConceptScore W2322834306C99454951 @default.
- W2322834306 hasIssue "1" @default.
- W2322834306 hasLocation W23228343061 @default.
- W2322834306 hasOpenAccess W2322834306 @default.
- W2322834306 hasPrimaryLocation W23228343061 @default.
- W2322834306 hasRelatedWork W195854409 @default.
- W2322834306 hasRelatedWork W2009588589 @default.
- W2322834306 hasRelatedWork W2032958076 @default.
- W2322834306 hasRelatedWork W2035331946 @default.
- W2322834306 hasRelatedWork W2075372262 @default.
- W2322834306 hasRelatedWork W2080033839 @default.
- W2322834306 hasRelatedWork W2329290186 @default.
- W2322834306 hasRelatedWork W2970916347 @default.
- W2322834306 hasRelatedWork W3015996685 @default.
- W2322834306 hasRelatedWork W4233016836 @default.
- W2322834306 hasVolume "21" @default.
- W2322834306 isParatext "false" @default.
- W2322834306 isRetracted "false" @default.
- W2322834306 magId "2322834306" @default.
- W2322834306 workType "article" @default.